O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort. - Wikidata - wikimedia - TriplyDB

O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort.

O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort.

http://www.wikidata.org/entity/Q38436906

about

Molecular Biology in Pediatric High-Grade Glioma: Impact on Prognosis and Treatment Molecular and phenotypic characterisation of paediatric glioma cell lines as models for preclinical drug development Silencing of MGMT expression by promoter hypermethylation in the metaplasia-dysplasia-carcinoma sequence of Barrett's esophagus Advances in the management of paediatric high-grade glioma.A phase I trial of temozolomide and lomustine in newly diagnosed high-grade gliomas of childhood.Homogeneous MGMT immunoreactivity correlates with an unmethylated MGMT promoter status in brain metastases of various solid tumors.O6-Methylguanine-DNA methyltransferase protein expression by immunohistochemistry in brain and non-brain systemic tumours: systematic review and meta-analysis of correlation with methylation-specific polymerase chain reaction.Childhood brain tumors: epidemiology, current management and future directions.Dissecting DNA repair in adult high grade gliomas for patient stratification in the post-genomic era.Differences in molecular genetics between pediatric and adult malignant astrocytomas: age matters.Mismatch repair deficiency is an uncommon mechanism of alkylator resistance in pediatric malignant gliomas: a report from the Children's Oncology Group.Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group.Overcoming temozolomide resistance in glioblastoma via dual inhibition of NAD+ biosynthesis and base excision repair Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markers N-methylpurine DNA glycosylase and DNA polymerase beta modulate BER inhibitor potentiation of glioma cells to temozolomide O6-methylguanine DNA methyltransferase deficiency and response to temozolomide-based therapy in patients with neuroendocrine tumors.Impact of tumor location and pathological discordance on survival of children with midline high-grade gliomas treated on Children's Cancer Group high-grade glioma study CCG-945.Proliferative and metabolic markers in incompletely excised pediatric pilocytic astrocytomas--an assessment of 3 new variables in predicting clinical outcome.A multi-institutional experience in pediatric high-grade glioma.Management of high-grade gliomas in the pediatric patient: Past, present, and future.DNA repair: from genome maintenance to biomarker and therapeutic target.Outcomes of pediatric glioblastoma treated with adjuvant chemoradiation with temozolomide and correlation with prognostic factors Long-term follow-up of children treated for high-grade gliomas: children's oncology group L991 final study report.Base excision repair: contribution to tumorigenesis and target in anticancer treatment paradigms Long-term survival of children less than six years of age enrolled on the CCG-945 phase III trial for newly-diagnosed high-grade glioma: a report from the Children's Oncology Group Interplay among BRAF, p16, p53, and MIB1 in pediatric low-grade gliomas.O-6-Methylguanine-DNA methyltransferase expression is associated with pituitary adenoma tumor recurrence: a systematic meta-analysis Tumor Suppressor WWOX and p53 Alterations and Drug Resistance in Glioblastomas.Diagnostic and therapeutic stratification of childhood brain tumors: implications for translational research.Molecular diagnostic testing in malignant gliomas: a practical update on predictive markers.Phase II study of cilengitide in the treatment of refractory or relapsed high-grade gliomas in children: a report from the Children's Oncology Group.Downregulation of miR-137 and miR-6500-3p promotes cell proliferation in pediatric high-grade gliomas.Irradiation of pediatric high-grade spinal cord tumors.Double-labelling immunohistochemistry for MGMT and a "cocktail" of non-tumourous elements is a reliable, quick and easy technique for inferring methylation status in glioblastomas and other primary brain tumours.Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy.Pediatric high-grade gliomas and diffuse intrinsic pontine gliomas.Molecular diagnostics of gliomas: state of the art.Treatment of pituitary neoplasms with temozolomide: a review.Treatment of high-grade glioma in children and adolescents.Temozolomide responsiveness in aggressive corticotroph tumours: a case report and review of the literature.

P2860

Q26785952-524EDA94-C186-4F99-8364-750C30F6E6EF Q28475285-631EE1BD-9F9B-4F33-AB8D-1CC6E517B7D2 Q30412980-1316C4A7-1DFA-4BF8-83C6-03CA3D9AA89A Q30870633-96647AF2-2D48-472D-B782-F69BD55E523E Q33379701-17496659-8CC5-4A4F-A75D-1659F537996F Q33416431-33A56CE1-4A11-488F-93CB-2C7E71358FCE Q33804528-1DE6C0E4-6543-41D2-ACB3-1B347F9F7437 Q33970971-43939947-2B76-46AA-86EC-E2A57643BF36 Q34221722-18C3335E-F9D0-40D5-A9C4-8C7E386AEED4 Q34286305-5536D10C-743C-4826-A3E7-76A4AEE69855 Q34565801-7FDCE068-50D2-48B5-A028-20B39B6F385F Q34722440-42B74F09-D081-4670-9A35-960CCE72AA22 Q34802264-6CD9946B-ED22-4593-B469-ECDC28724123 Q34815207-9075130F-0084-4F7D-AB50-5C74A7DA635D Q34977358-A3698FE4-E8C5-4B1E-9552-EA8A034271B6 Q35001754-41DEDE9B-99FC-4906-B3D2-146B4A24F43F Q35070545-82B62A41-34AB-4967-8D21-BA6C49A7BE12 Q35085329-5A6F6116-4F17-49A9-80DE-6F2C9329AF92 Q35094432-6CECE248-24AF-4921-B647-1F77B7E85A0C Q35206259-717120BF-377E-43C0-A8C1-E0B0A9EF980C Q35555880-B2313DDC-B005-41A9-A522-055B2A3AF168 Q35769714-08506AC0-D9F7-451A-AA14-9553B15C1258 Q35925137-B247A038-8AB1-4531-BF1D-5C3619B0D3BF Q35955906-5500006A-A252-4C10-8FEC-1FAC680DBD5F Q35972863-3575E380-3A5E-4A71-88BE-CCFF88730A3D Q36010103-1210E0FC-EF45-47B0-A20E-67533C5801A4 Q36268061-4D0B812E-B772-4513-A156-A85225542294 Q36651893-0AE90C31-28EA-4879-933A-8873F1D50E16 Q36908083-68AC1BCB-4026-4D11-92CE-DC419179DCA8 Q37037132-1C704FAD-5973-49BD-BEA4-24934A033573 Q37187676-13FAEC11-186F-4660-83CE-474F87C416EF Q37190159-F73650AE-0C3C-4E3A-AE03-63EFD44ACD97 Q37394315-D866599F-F1DC-40F3-8753-C0F9C3C4819B Q37485637-13494E77-A367-40D5-ABE5-9E295CE973D4 Q37564201-589F4E2B-9A44-4B76-B3F8-76B100EFBE8D Q37564835-B9F43A88-1F75-4284-8A3B-1086A1F88D3B Q37780495-B78420A1-B314-4A60-921B-8FD953204DEF Q37789267-5D1BD3B0-9DEB-4EBE-8F14-F4F3C618828C Q37904503-0EBF3691-54C2-407E-91B9-B12373EA00C8 Q37955091-BFCBA4AF-46B5-45B4-BEA4-5C80436578A5

P2860

O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort.

http://www.wikidata.org/entity/Q38436906

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

O6-methylguanine-DNA methyltra ...... sults from the CCG-945 Cohort.

@en

type

label

O6-methylguanine-DNA methyltra ...... sults from the CCG-945 Cohort.

@en

prefLabel

O6-methylguanine-DNA methyltra ...... sults from the CCG-945 Cohort.

@en

P1433

Q38436906-7A3926C7-9ADD-4CE6-8909-F329FEF97A31

P1476

Q38436906-FCD47F5B-47B1-4955-9FE9-0588200DF772

P2093

Q38436906-0594E5D0-8D6F-4157-BE50-794700994D8B

Q38436906-5A8F886C-75E1-4957-9EB1-9EB7BCA881D7

Q38436906-7A1F5D3E-B210-46F7-8CDD-D64B57BBD0F2

Q38436906-911EED0A-C783-4A19-8CC1-EC14BCDBF48A

Q38436906-9EF0AB5C-8B2C-4FB5-9A20-B7A9FD09F9D3

Q38436906-EFFEC3EA-0A1B-46AA-BAC1-7FBC0974902D

Q38436906-F726911A-7182-41DD-A2F9-C293BDC2030B

Q38436906-FC0EFC76-5DD3-402D-A285-AF374C61BE3E

P304

Q38436906-8BB29F48-6E43-47B4-910C-1DA2295FF59A

P31

Q38436906-CF86F81E-6592-4BB7-9FAD-9751543E64C3

P356

Q38436906-B3622565-F7A1-4FE9-8DF7-B0D376834031

P407

Q38436906-9B648142-FC6A-4B79-AB5C-1B5241D0B967

P433

Q38436906-46B85676-40C7-4B09-88DA-A5FCD0AFF22A

P478

Q38436906-5E666805-E39B-4160-9FBD-6BF7ED8D37F6

P577

Q38436906-74F1690A-BE0D-47AD-83FA-1815328A5394

P698

Q38436906-AD227D33-ADAB-42EE-951B-2DB024E3B564

P356

JCO.2006.05.7265

P1433

Journal of Clinical Oncology

P1476

O6-methylguanine-DNA methyltra ...... sults from the CCG-945 Cohort.

@en

P2093

Allan J Yates

http://www.w3.org/2001/XMLSchema#string

Emiko J Holmes

http://www.w3.org/2001/XMLSchema#string

Ian F Pollack

http://www.w3.org/2001/XMLSchema#string

Jonathan L Finlay

http://www.w3.org/2001/XMLSchema#string

Judith Burnham

http://www.w3.org/2001/XMLSchema#string

Robert W Sobol

http://www.w3.org/2001/XMLSchema#string

Ronald L Hamilton

http://www.w3.org/2001/XMLSchema#string

Tianni Zhou

http://www.w3.org/2001/XMLSchema#string

P304

3431-3437

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2006.05.7265

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2006-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16849758

http://www.w3.org/2001/XMLSchema#string